The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes.

doi:10.1016/0922-4106(95)90029-2

Paper

DOI: 10.1016/0922-4106(95)90029-2

The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes.

Published Jul 18, 1995 · A. D. Campbell, D. Womer, J. Simon

European journal of pharmacology

Q1 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

The 5-HT3 receptor agonist 1-(m-chlorophenyl)-biguanide interacts with the dopamine transporter in rat brain synaptosomes, with varying effects in caudate putamen and nucleus accumbens regions.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Sign up to use Study Snapshot

Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.

Create an account

Full text analysis coming soon...

References

DOI: 10.1046/j.1471-4159.1994.62020543.x

Age‐Dependent Alterations in Dopamine Content, Tyrosine Hydroxylase Activity, and Dopamine Uptake in the Striatum of the Weaver Mutant Mouse

The weaver mutation causes age-dependent alterations in dopamine content, tyrosine hydroxylase activity, and dopamine uptake in the striatal region of mice, potentially targeting the striatal dopamine transporter early in life.

1994·20citations·J. Simon et al.·Journal of Neurochemistry

Journal of Neurochemistry

DOI: 10.1046/j.1471-4159.1994.62010342.x

[3H] GBR‐12935 Binding to Cytochrome P450 in the Human Brain

[3H] GBR-12935 binding to piperazine acceptor sites in the human brain suggests that at least part of this fraction represents cytochrome P450IID6, the human form of P450IID1.

1994·33citations·P. Allard et al.·Journal of Neurochemistry

Journal of Neurochemistry

DOI: 10.1097/00008571-199308000-00003

Pharmacogenetics of cocaine: II. Mesocorticolimbic and striatal dopamine and cocaine receptors in C57BL and DBA mice.

Strain differences in striatal D2 receptors may contribute to genetic differences in cocaine-related behaviors in C57BL/6 and DBA/2 mice.

1993·28citations·V Gene Erwin et al.·Pharmacogenetics

Pharmacogenetics

DOI: 10.1016/s0022-3565(25)38133-4

Serotonin-facilitated dopamine release in vivo: pharmacological characterization.

Serotonin agonists enhance dopamine release in the brain, with 5-HT1b, 5-HT3, and 5-HT4 receptors being involved, but not 5-HT2 receptors.

1993·254citations·S. Benloucif et al.·The Journal of pharmacology and experimental therapeutics

The Journal of pharmacology and experimental therapeutics

DOI: 10.1016/s0022-3565(25)10163-8

Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats.

The peripheral 5-HT3 receptor agonists PBG and mCPBG cause aversive-type behaviors in rats, potentially related to gastrointestinal discomfort, while central injections produce dopamine-related behaviors.

1993·44citations·Guy A. Higgins et al.·The Journal of pharmacology and experimental therapeutics

The Journal of pharmacology and experimental therapeutics

Citations

DOI: 10.1631/jzus.B2200642

Role of 5-hydroxytryptamine type 3 receptors in the regulation of anxiety reactions

5-HT_3Rs play a bidirectional role in anxiety reactions, potentially aiding in the treatment of anxiety disorders or anxiolytic drugs.

2024·1citation·Yinan Du et al.·Journal of Zhejiang University-SCIENCE B

Journal of Zhejiang University-SCIENCE B

DOI: 10.1016/j.bbrc.2018.11.174

SR 57227A is a partial agonist/partial antagonist of 5-HT3 receptor and inhibits subsequent 5-HT- or SR 57227A-induced 5-HT3 receptor current.

SR 57227A acts as a partial agonist/partial antagonist at the 5-HT3 receptor, potentially acting as a serotonin stabilizer.

2019·0citations·Yukiko Nakamura et al.·Biochemical and biophysical research communications

Biochemical and biophysical research communications

DOI: 10.1155/2015/945217

Molecular and Functional Characterization of Bacopa monniera: A Retrospective Review

Bacopa monniera extract can attenuate dementia and enhance memory, primarily through neuroprotection and altering serotonin levels, which play a key role in memory formation.

2015·37citations·K. E. Rajan et al.·Evidence-based Complementary and Alternative Medicine : eCAM

Evidence-based Complementary and Alternative Medicine : eCAM

DOI: 10.1016/j.bbr.2012.01.056

Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol

Propranolol, ondansetron, and buspirone effectively reduce anxiety and locomotor activity in rats after 24 hours and 7 days of cocaine withdrawal, depending on the withdrawal period.

2012·29citations·M. Citó et al.·Behavioural Brain Research

Behavioural Brain Research

DOI: 10.1007/s11064-011-0538-7

Attenuation of 1-(m-Chlorophenyl)-Biguanide Induced Hippocampus-Dependent Memory Impairment by a Standardised Extract of Bacopa monniera (BESEB CDRI-08)

BESEB CDRI-08 improves hippocampal-dependent memory by acting on serotonergic system and influencing cholinergic system through 5-HT3 receptors.

2011·39citations·K. Emmanuvel Rajan et al.·Neurochemical Research

Neurochemical Research